GeneDx Holdings Corp

詳細情報企業名

企業情報

企業コードWGS

会社名GeneDx Holdings Corp

上場日Sep 04, 2020

最高経営責任者「CEO」Ms. Katherine A. Stueland

従業員数1000

証券種類Ordinary Share

決算期末Sep 04

本社所在地333 Ludlow Street

都市STAMFORD

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号06902

電話番号18887291206

ウェブサイトhttps://sema4.com/

企業コードWGS

上場日Sep 04, 2020

最高経営責任者「CEO」Ms. Katherine A. Stueland

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Kevin Feeley

Chief Financial Officer

9.12K

+121.37%

Mr. Keith A. Meister

Independent Director

3.58K

-82.23%

Dr. Thomas Fuchs

Director

--

Dr. Bryan Dechairo

Chief Operating Officer

--

Ms. Katherine A. Stueland

Chief Executive Officer, Director

--

Mr. Jason Michael Ryan, CPA

Chairman of the Board

--

Mr. Eli D. Casdin

Independent Director

--

Mr. Richard C. (Rick) Pfenniger, Jr.

Independent Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Kevin Feeley

Chief Financial Officer

9.12K

+121.37%

Mr. Keith A. Meister

Independent Director

3.58K

-82.23%

Dr. Thomas Fuchs

Director

--

Dr. Bryan Dechairo

Chief Operating Officer

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Patients with third party insurance

68.06M

78.13%

Institutional customers

17.60M

20.21%

Other

1.36M

1.56%

Self pay patients

96.00K

0.11%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Patients with third party insurance

68.06M

78.13%

Institutional customers

17.60M

20.21%

Other

1.36M

1.56%

Self pay patients

96.00K

0.11%

株主

更新時刻: Sat, Aug 16

株主統計

種類

株主統計

比率

Corvex Management LP

10.65%

Casdin Capital, LLC

10.60%

William Blair Investment Management, LLC

5.68%

Icahn School of Medicine at Mount Sinai

4.78%

OPKO Health Inc

4.77%

他の

63.52%

株主統計

比率

Corvex Management LP

10.65%

Casdin Capital, LLC

10.60%

William Blair Investment Management, LLC

5.68%

Icahn School of Medicine at Mount Sinai

4.78%

OPKO Health Inc

4.77%

他の

63.52%

種類

株主統計

比率

Hedge Fund

36.39%

Investment Advisor/Hedge Fund

35.06%

Investment Advisor

30.43%

Corporation

10.71%

Research Firm

6.56%

Individual Investor

1.68%

Pension Fund

0.81%

Venture Capital

0.54%

Bank and Trust

0.48%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

397

34.23M

119.24%

+1.02M

2025Q1

398

32.79M

115.46%

-47.86K

2024Q4

341

29.17M

104.22%

+1.72M

2024Q3

289

26.18M

97.50%

+377.48K

2024Q2

262

24.98M

95.33%

+588.25K

2024Q1

260

22.13M

86.19%

+1.41M

2023Q4

271

20.57M

80.67%

-567.28K

2023Q3

283

21.68M

85.29%

-751.02K

2023Q2

291

21.85M

86.03%

-864.88K

2023Q1

296

21.58M

684.27%

+3.47M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Corvex Management LP

2.91M

10.19%

+434.85K

+17.58%

May 05, 2025

Casdin Capital, LLC

3.53M

12.36%

--

May 05, 2025

William Blair Investment Management, LLC

1.19M

4.17%

+518.99K

+77.46%

Mar 31, 2025

Icahn School of Medicine at Mount Sinai

1.37M

4.81%

-1.35M

-49.50%

Feb 21, 2025

OPKO Health Inc

1.37M

4.8%

-800.83K

-36.88%

Nov 20, 2024

BlackRock Institutional Trust Company, N.A.

1.04M

3.64%

-41.94K

-3.89%

Mar 31, 2025

The Vanguard Group, Inc.

1.03M

3.6%

+23.46K

+2.34%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

503.73K

1.77%

+503.73K

--

Mar 31, 2025

詳細を見る

117.210USD

GeneDx Holdings Corp

117.210

概要

企業名

金融

分析